Published in J Infect Dis on January 01, 1989
Updated functional classification of beta-lactamases. Antimicrob Agents Chemother (2009) 7.16
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev (1997) 6.98
Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother (1990) 1.59
Characterization of mechanisms of resistance to beta-lactam antibiotics in methicillin-resistant strains of Staphylococcus saprophyticus. Antimicrob Agents Chemother (1990) 1.41
Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.41
Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure. Antimicrob Agents Chemother (2009) 1.35
Characterization of a chromosomal gene encoding type B beta-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob Agents Chemother (1998) 1.16
Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus. Antimicrob Agents Chemother (2002) 1.15
Relative efficacies of broad-spectrum cephalosporins for treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis. Antimicrob Agents Chemother (1993) 1.09
In vivo effect of cefazolin, daptomycin, and nafcillin in experimental endocarditis with a methicillin-susceptible Staphylococcus aureus strain showing an inoculum effect against cefazolin. Antimicrob Agents Chemother (2013) 1.00
Comparison of the beta-lactamase gene cluster in clonally distinct strains of Enterococcus faecalis. Antimicrob Agents Chemother (1996) 0.97
Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2012) 0.97
RWJ-54428 (MC-02,479), a new cephalosporin with high affinity for penicillin-binding proteins, including PBP 2a, and stability to staphylococcal beta-lactamases. Antimicrob Agents Chemother (2003) 0.96
Structure-function relationships among wild-type variants of Staphylococcus aureus beta-lactamase: importance of amino acids 128 and 216. J Bacteriol (1996) 0.95
Purification of Staphylococcus aureus beta-lactamases by using sequential cation-exchange and affinity chromatography. Antimicrob Agents Chemother (1990) 0.92
Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J Clin Microbiol (1998) 0.92
Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals. J Antimicrob Chemother (2013) 0.89
Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model. Antimicrob Agents Chemother (1993) 0.88
Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic. Antimicrob Agents Chemother (2011) 0.83
Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome. Eur J Clin Microbiol Infect Dis (2014) 0.83
Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase. J Mol Biol (2011) 0.81
Cephalosporins--cefotaxime 10 years later, a major drug with continued use. Infection (1991) 0.79
Relative beta-lactamase- and transpeptidase-inhibitory activities of the new quinolone WIN-57273 in Staphylococcus aureus. Antimicrob Agents Chemother (1992) 0.75
Production of A and C variants of staphylococcal beta-lactamase by methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1994) 0.75
Association between type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2016) 0.75
Efficacy of Ceftaroline in a Rat Model of Endocarditis Against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High Inoculum Effect. Antimicrob Agents Chemother (2017) 0.75
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann Neurol (1999) 5.83
Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests. J Infect Dis (1977) 4.00
Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent. J Infect Dis (1977) 3.15
CSF oligoclonal bands in MS include antibodies against Chlamydophila antigens. Neurology (2001) 2.88
Controlled evaluation of BACTEC Plus 26 and Roche Septi-Chek aerobic blood culture bottles. J Clin Microbiol (1991) 2.62
Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother (1981) 2.04
Spontaneous bacterial peritonitis. A review of 28 cases with emphasis on improved survival and factors influencing prognosis. Am J Med (1978) 2.04
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00
Controlled evaluation of the agar-slide and radiometric blood culture systems for the detection of bacteremia and fungemia. J Clin Microbiol (1986) 1.98
Controlled evaluation of BACTEC PLUS 27 and Roche Septi-Chek anaerobic blood culture bottles. J Clin Microbiol (1992) 1.92
Multicenter collaborative evaluation of a standardized serum bactericidal test as a prognostic indicator in infective endocarditis. Am J Med (1985) 1.92
Correlation of serum bactericidal activity with antimicrobial agent level and minimal bactericidal concentration. J Infect Dis (1982) 1.74
Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis (1983) 1.72
Comparison of the Staph-Ident system with a conventional method for species identification of urine and blood isolates of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.66
Effective treatment of multidrug-resistant enterococcal experimental endocarditis with combinations of cell wall-active agents. J Infect Dis (1996) 1.63
Use of extracts versus whole-cell bacterial suspensions in the identification of Staphylococcus aureus beta-lactamase variants. Antimicrob Agents Chemother (1990) 1.59
Characterization of four beta-lactamases produced by Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.41
Thermonuclease test for same-day identification of Staphylococcus aureus in blood cultures. J Clin Microbiol (1985) 1.40
The expanding horizons of infection control. Infect Control Hosp Epidemiol (1995) 1.39
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies. Antimicrob Agents Chemother (1987) 1.23
Effect of salts on penicillinase release by Staphylococcus aureus. Microbios (1975) 1.22
Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis (1996) 1.22
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
In vitro pharmacodynamics of piperacillin, piperacillin-tazobactam, and ciprofloxacin alone and in combination against Staphylococcus aureus, Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 1.19
Microbial flora of pecan meat. Appl Microbiol (1971) 1.16
Inhibition of Aspergillus growth and aflatoxin release by derivatives of benzoic acid. Appl Environ Microbiol (1980) 1.14
Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis. Am J Med (1987) 1.10
Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1992) 1.09
Sensitivity, specificity, and predictive value of body surface cultures in a neonatal intensive care unit. JAMA (1988) 1.08
Candidal suppurative peripheral thrombophlebitis. Ann Intern Med (1982) 1.08
Endemic staphylococcal pseudobacteremia. Infect Control (1981) 1.06
Ochratoxins. Adv Appl Microbiol (1973) 1.06
Diminished activity of ceftizoxime in comparison to cefotaxime and ceftriaxone against Streptococcus pneumoniae. Clin Infect Dis (1995) 1.06
Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1985) 1.03
Growth of Staphylococcus aureus with nafcillin in vitro induces alpha-toxin production and increases the lethal activity of sterile broth filtrates in a murine model. J Infect Dis (1995) 1.01
Daily variations in the production of aflatoxins by Aspergillus flavus NRRL-3145 following exposure to 60 Co irradiation. J Appl Bacteriol (1974) 1.00
Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media. J Clin Microbiol (1995) 1.00
Tuberculoid tenosynovitis and carpal tunnel syndrome caused by Mycobacterium szulgai. Am J Med (1978) 0.99
Epidemiological spectrum and current treatment of listeriosis. Rev Infect Dis (1992) 0.97
Comparison of effects of sublethal microwave radiation and conventional heating on the metabolic activity of Staphylococcus aureus. Appl Environ Microbiol (1980) 0.97
Effects of various acids and salts on growth and aflatoxin production by Aspergillus flavus NRRL 3145. Microbios (1976) 0.96
Utilization of time-kill kinetic methodologies for assessing the bactericidal activities of ampicillin and bismuth, alone and in combination, against Helicobacter pylori in stationary and logarithmic growth phases. Antimicrob Agents Chemother (1995) 0.95
Controlled evaluation of modified radiometric blood culture medium supplemented with gelatin for detection of bacteremia and fungemia. J Clin Microbiol (1987) 0.93
Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J Clin Microbiol (1998) 0.92
Purification of Staphylococcus aureus beta-lactamases by using sequential cation-exchange and affinity chromatography. Antimicrob Agents Chemother (1990) 0.92
Comparison of kill-kinetic studies with agar and broth microdilution methods for determination of antimicrobial activity of selected agents against members of the Bacteroides fragilis group. J Clin Microbiol (1987) 0.92
Localization of gonococcal lipopolysaccharide and its relationship to toxic damage in human fallopian tube mucosa. Infect Immun (1986) 0.91
Rapid diagnosis of Candida sepsis in surgical patients. Am Surg (1987) 0.91
Hemophilus influenzae pneumonia in adults: report of five cases caused by ampicillin-resistant strains. Am Rev Respir Dis (1980) 0.90
Effects of 60Co gamma irradiation on aflatoxin B1 and B2 production by Aspergillus flavus. Mycologia (1974) 0.90
Comparison of the effect of refrigerated versus room temperature media on the isolation of Neisseria gonorrhoeae from genital specimens. J Clin Microbiol (1985) 0.89
Microbial production of lysine and threonine from whey permeate. Appl Environ Microbiol (1983) 0.89
Synergistic resistance mechanisms in Pseudomonas aeruginosa. J Antimicrob Chemother (1987) 0.89
Increased aflatoxin production by Aspergillus flavus via cobalt irradiation. Poult Sci (1973) 0.88
Cholesterol metabolism by Mycobacterium. Microbios (1975) 0.87
Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori. Antimicrob Agents Chemother (1995) 0.87
Cationic uptake and exchange in Salmonella enteritidis. Can J Microbiol (1972) 0.86
Falsely elevated serum creatinine levels secondary to the presence of 5-fluorocytosine. Am J Clin Pathol (1985) 0.85
Production of ochratoxin A by Aspergillus ochraceus NRRL-3174 before and after exposures to 60Co irradiation. Appl Environ Microbiol (1976) 0.85
Tissue distribution and metabolism of aflatoxin B 1 - 14 C in Broiler chickens. Appl Microbiol (1973) 0.84
Chronic mycotoxicosis in chicks caused by toxins from Phomopsis grown on soybeans. J Comp Pathol (1977) 0.84
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori. J Antimicrob Chemother (1998) 0.84
The formulary: an educational tool for clinical pharmacology. Clin Pharmacol Ther (1992) 0.84
Increased aflatoxin G1 production by Aspergillus flavus via gamma irradiation. Mycologia (1974) 0.83
Granulomatous tenosynovitis and carpal tunnel syndrome caused by Sporothrix schenckii. Am J Med (1981) 0.83
Regulation by IFN-beta of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens. J Interferon Cytokine Res (2001) 0.82
Effects of microwave irradiation on microorganisms. Adv Appl Microbiol (1980) 0.82
Evaluation of spot CAMP test for identification of group B streptococci. J Clin Microbiol (1986) 0.81
Susceptibility testing revisited. Prog Clin Pathol (1984) 0.81
High-level aminoglycoside-resistant enterococcus causing endocarditis successfully treated with a combination of ampicillin, imipenem and vancomycin. Scand J Infect Dis (1997) 0.80
Vancomycin entry into lung lymph in sheep. Antimicrob Agents Chemother (1987) 0.80
Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1986) 0.79
Bacterial pneumonias--an overview with emphasis on pathogenesis, diagnosis, and treatment. Heart Lung (1986) 0.79
Assessment of the bactericidal activity of sparfloxacin, ofloxacin, levofloxacin, and other fluoroquinolones compared with selected agents of proven efficacy against Listeria monocytogenes. Diagn Microbiol Infect Dis (1994) 0.79
Role of biotin in the production of lysine by Brevibacterium lactofermentum. Microbios (1984) 0.78
Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms. Diagn Microbiol Infect Dis (1989) 0.78
Bactericidal activity of ceftizoxime, cefotetan, and clindamycin against cefoxitin-resistant strains of the Bacteroides fragilis group. J Antimicrob Chemother (1991) 0.78
Chlamydia pneumoniae and chronic skin wounds: a focused review. J Investig Dermatol Symp Proc (2001) 0.78
Infection related to intravenous infusions. Heart Lung (1982) 0.78
The usefulness of the serum bactericidal test in orthopedic infections. Orthopedics (1984) 0.78
Conditions for induction of bacteriophage from lysogenic Bacillus megaterium with aflatoxin B1. Appl Environ Microbiol (1979) 0.77
Pseudomonas aeruginosa. Infect Control (1983) 0.77
Susceptibility testing of Listeria monocytogenes. A reassessment of bactericidal activity as a predictor for clinical outcome. Diagn Microbiol Infect Dis (1991) 0.76
Effect of human serum on inhibition of growth of Staphylococcus aureus by antimicrobial agents. Eur J Clin Microbiol (1986) 0.76
Nursery epidemic due to multiply-resistant Klebsiella pneumoniae: epidemiologic setting and impact on perinatal health care delivery. Infect Control (1982) 0.75
Comparative evaluation of radiometric tryptic soy broth versus radiometric tryptic soy broth with 10% sucrose for detection of bacteremia and fungemia in pediatric patients. J Clin Microbiol (1989) 0.75
Survival of aerobic and anaerobic bacteria in chicken meat during freeze-dehydration, rehydration, and storage. Appl Microbiol (1968) 0.75
Production of A and C variants of staphylococcal beta-lactamase by methicillin-resistant strains of Staphylococcus aureus. Antimicrob Agents Chemother (1994) 0.75
In vitro comparison of clindamycin and pirlimycin (U-57930E) activity against Staphylococcus aureus. Antimicrob Agents Chemother (1982) 0.75
Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa. J Antimicrob Chemother (1987) 0.75
Further characterization of tissue distribution and metabolism of (14C)aflatoxin B1 in chickens. Appl Microbiol (1974) 0.75
Comparison of the antigenicity of phenol and ethylenediaminetetraacetate complexes isolated from cell walls of Salmonella enteritidis. Appl Microbiol (1972) 0.75
Antimicrobial treatment of multiple sclerosis. Infection (2007) 0.75
Beta-lactamase alteration of beta-lactam inhibitory zones. Eur J Clin Microbiol (1987) 0.75
Waterless agents for decontaminating the hands. Infect Control (1986) 0.75
Standardization of the serum bactericidal test and its relationship to levels of antimicrobial agents. Eur J Clin Microbiol (1986) 0.75
Esophageal candidiasis: treatment with ketoconazole. South Med J (1983) 0.75
The role of the microbiology laboratory in guiding formulary decisions. Hosp Formul (1988) 0.75